Szymanska Heydel, Maja
Heindl, Felix
Hartmann, Annette
Borsche, Max
Traschütz, Andreas
Straumann, Dominik
Strupp, Michael
Tarnutzer, Alexander Andrea
Funding for this research was provided by:
University of Zurich
Article History
Accepted: 11 March 2025
First Online: 20 March 2025
Declarations
:
: Being a systematic review of the literature and a meta-analysis, no ethical approval was necessary.
: The authors did not receive support from any organization for the submitted work. M. Strupp is Joint Chief Editor of the Journal of Neurology, Editor in Chief of Frontiers of Neuro-otology and Section Editor of F1000. He has received speaker’s honoraria from Abbott, Auris Medical, Biogen, Eisai, Grünenthal, GSK, Henning Pharma, Interacoustics, J&J, MSD, NeuroUpdate, Otometrics, Pierre-Fabre, TEVA, UCB, and Viatris. He receives support for clinical studies from Decibel, U.S.A., Cure within Reach, U.S.A. and Heel, Germany. He distributes “M-glasses” and “Positional vertigo App”. He acts as a consultant for Abbott, AurisMedical, Bulbitec, Heel, IntraBio, Sensorion, Vifor and Vertify. He is investor and share- and patent-holder of IntraBio. The other authors have no relevant financial or non-financial interests to disclose.